atorvastatin has been researched along with Systolic Heart Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernste, F; Pitlick, M | 1 |
| Abulhul, E; Baugh, J; Hennessy, M; Ledwidge, M; Martos, R; McDonald, K; O'Loughlin, C; Phelan, D; Spiers, JP; Watson, C | 1 |
1 trial(s) available for atorvastatin and Systolic Heart Failure
| Article | Year |
|---|---|
Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Atorvastatin; Biomarkers; Chi-Square Distribution; Cholesterol; Collagen; Collagen Type I; Down-Regulation; Female; Heart Failure, Systolic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Ireland; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peptides; Procollagen; Prospective Studies; Pyrroles; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Up-Regulation; Ventricular Function, Left | 2012 |
1 other study(ies) available for atorvastatin and Systolic Heart Failure
| Article | Year |
|---|---|
Anti-HMGCR myopathy presenting with acute systolic heart failure.
Topics: Aged; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Creatine Kinase; Female; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl CoA Reductases; Methylprednisolone; Muscle Weakness; Muscular Diseases; Treatment Outcome | 2019 |